There is no fund objective available from this fund manager.
Name | % Net Assets |
---|---|
BP | 8.1% |
HSBC | 6.8% |
Vodafone | 6.7% |
GlaxoSmithKline | 5.4% |
The Royal Bank of Scotland | 4.4% |
AstraZeneca | 3.4% |
Shell Transport & Trading | 2.9% |
Aberforth UK Smaller Companies Fund | 2.7% |
Barclays | 2.4% |
Anglo American | 2.0% |
Key | % Net Assets |
---|---|
BP | 8.1% |
HSBC | 6.8% |
Vodafone | 6.7% |
GlaxoSmithKline | 5.4% |
Other | 73% |
Date | 11-May-2017 |
---|---|
NAV | 400.20p |
Currency | GBP |
Change | 1.00p |
% | 0.25% |
YTD change | 400.20p |
YTD % | n/a |
Fund Inception | n/a |
---|---|
Fund Manager | n/a |
TER | - |
Minimum Investment | |
---|---|
Initial | n/a |
Additional | n/a |
Savings | n/a |
Charges | |
---|---|
Initial | n/a |
Annual Mang't | n/a |
Exit | n/a |
Name | % |
---|---|
Standard deviation | 0.02 |
Sharpe ratio | 0.06 |
You are here: research